agnesjanejennings

[agnesjanejennings]

Large U.S. pharmacy chains played role in opioid crisis, lawsuit claims

(HealthDay)—Large pharmacy chains, including CVS, Rite Aid, Walgreens, Giant Eagle, and those operated by Walmart, played a role in the U.S. opioid epidemic, alleges a lawsuit filed in federal court in Cleveland by two Ohio counties.

[agnesjanejennings]

Even with private insurance, black overdose patients are half as likely as whites to get addiction treatment

Opioid overdose patients with private insurance are rarely connected to addiction treatment after visiting the emergency department, a new national study from the University of Pennsylvania has found.

[agnesjanejennings]

Opioid prescribing down for minor ortho injuries in youth

(HealthDay)—From 2004 to 2017, there was a decrease in the proportion of pediatric patients with a minor injury prescribed opioids, according to research released as part of the American Academy of Orthopaedic Surgeons Virtual Education Experience.

[agnesjanejennings]

Study: Public health campaigns can do better on cannabis harm reduction

Harm reduction strategies have proven effective for use of opioids, alcohol, and tobacco products. University at Buffalo and University of Michigan researchers say harm reduction techniques also have potential for cannabis users—but first, public health practitioners and organizations need to do a better job of making cannabis users aware of those strategies.

[agnesjanejennings]

Large U.S. pharmacy chains played role in opioid crisis, lawsuit claims

(HealthDay)—Large pharmacy chains, including CVS, Rite Aid, Walgreens, Giant Eagle, and those operated by Walmart, played a role in the U.S. opioid epidemic, alleges a lawsuit filed in federal court in Cleveland by two Ohio counties.

[agnesjanejennings]

Even with private insurance, black overdose patients are half as likely as whites to get addiction treatment

Opioid overdose patients with private insurance are rarely connected to addiction treatment after visiting the emergency department, a new national study from the University of Pennsylvania has found.

[agnesjanejennings]

Opioid prescribing down for minor ortho injuries in youth

(HealthDay)—From 2004 to 2017, there was a decrease in the proportion of pediatric patients with a minor injury prescribed opioids, according to research released as part of the American Academy of Orthopaedic Surgeons Virtual Education Experience.

[agnesjanejennings]

Study: Public health campaigns can do better on cannabis harm reduction

Harm reduction strategies have proven effective for use of opioids, alcohol, and tobacco products. University at Buffalo and University of Michigan researchers say harm reduction techniques also have potential for cannabis users—but first, public health practitioners and organizations need to do a better job of making cannabis users aware of those strategies.

[agnesjanejennings]

Users of high-potency cannabis four times more likely to report associated problems

Users of high-potency cannabis are four times more likely to report associated problems, and twice as likely to report anxiety disorder, than users of lower-potency strains, according to new research from the University of Bristol.

[agnesjanejennings]

New molecule stops drug cravings in mice, with fewer side effects

Duke University researchers have developed a synthetic molecule that selectively dampen the physiological rewards of cocaine in mice. It also may represent a new class of drugs that could be more specific with fewer side effects than current medications.

[agnesjanejennings]

New molecule stops drug cravings in mice, with fewer side effects

Duke University researchers have developed a synthetic molecule that selectively dampen the physiological rewards of cocaine in mice. It also may represent a new class of drugs that could be more specific with fewer side effects than current medications.

[agnesjanejennings]

Users of high-potency cannabis four times more likely to report associated problems

Users of high-potency cannabis are four times more likely to report associated problems, and twice as likely to report anxiety disorder, than users of lower-potency strains, according to new research from the University of Bristol.

[agnesjanejennings]

New molecule stops drug cravings in mice, with fewer side effects

Duke University researchers have developed a synthetic molecule that selectively dampen the physiological rewards of cocaine in mice. It also may represent a new class of drugs that could be more specific with fewer side effects than current medications.

[agnesjanejennings]

Users of high-potency cannabis four times more likely to report associated problems

Users of high-potency cannabis are four times more likely to report associated problems, and twice as likely to report anxiety disorder, than users of lower-potency strains, according to new research from the University of Bristol.

[agnesjanejennings]

New molecule stops drug cravings in mice, with fewer side effects

Duke University researchers have developed a synthetic molecule that selectively dampen the physiological rewards of cocaine in mice. It also may represent a new class of drugs that could be more specific with fewer side effects than current medications.

[agnesjanejennings]

Users of high-potency cannabis four times more likely to report associated problems

Users of high-potency cannabis are four times more likely to report associated problems, and twice as likely to report anxiety disorder, than users of lower-potency strains, according to new research from the University of Bristol.

[agnesjanejennings]

New molecule stops drug cravings in mice, with fewer side effects

Duke University researchers have developed a synthetic molecule that selectively dampen the physiological rewards of cocaine in mice. It also may represent a new class of drugs that could be more specific with fewer side effects than current medications.